CHRISTOPHER P KIRITSY

CIK 1261156 · last filed 2026-06-12

CHRISTOPHER P KIRITSY is a corporate insider who has filed 19 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for PVLA, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$34.0K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

19

Lifetime Open-Market Net

$34.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PVLA Director $157.77 $0 3 2026-06-12
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Director 250 $13.60 $3.4K $34.0K 14 2024-12-09
HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted Director $0.48 $0 2 2022-09-15

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 PVLA Grant (A) $0 EDGAR
2025-06-11 PVLA Grant (A) $0 EDGAR
2024-12-17 PVLA Grant (A) $0 EDGAR
2024-12-09 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
2023-06-23 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
2023-05-30 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Buy (P) +10,000 $8.5K EDGAR
2022-09-15 HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted Grant (A) $0 EDGAR
2022-06-24 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
2022-01-31 HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted Grant (A) $0 EDGAR
2021-06-29 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) $0 EDGAR
Showing 110 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.